Drug Screening Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

By: HDIN Research Published: 2025-05-18 Pages: 104
Market Research Report Price
  • Single User License (1 Users) $ 3,600
  • Team License (2~5 Users) $ 4,600
  • Corporate License (>5 Users) $ 5,600
Drug Screening Market Summary
Introduction and Market Overview
Drug screening involves testing biological samples to detect substances like illicit drugs, alcohol, and prescription medications, used in workplaces, healthcare, and law enforcement. The market is driven by rising global drug abuse, with 296 million people using drugs in 2021, and alcohol-related deaths accounting for 5.3% of global mortality. Chronic disease management and prescription drug abuse, particularly opioids, further fuel demand. Non-invasive methods like saliva and hair testing gain traction for their convenience. The global drug screening market is estimated at USD 5.0-9.0 billion in 2025, with a CAGR of 3.5%-7.3% through 2030.

Regional Market Trends
 North America: The U.S. leads due to workplace regulations and opioid crisis response, with Canada focusing on alcohol testing.
 Europe: Germany, France, and the UK drive growth with strict drug laws, emphasizing roadside testing.
 Asia Pacific: China and India see rising demand due to workplace safety initiatives, with Japan prioritizing sports doping tests.
 Rest of the World: Brazil expands screening in transportation, and the Middle East focuses on law enforcement applications.

Application Analysis
 Hospitals: Expected growth of 3.7%-7.5%, driven by patient monitoring. Trends focus on opioid abuse detection.
 Criminal Justice & Law Enforcement: Projected growth of 3.6%-7.4%, linked to drug trafficking control. Advances emphasize rapid roadside testing.
 Workplaces: Anticipated growth of 3.8%-7.6%, tied to safety regulations. Developments prioritize non-invasive methods.
 Others: Expected growth of 3.4%-7.2%, covering schools and individual users. Trends highlight home testing kits.

Type Analysis
 Instruments: Expected growth of 3.8%-7.6%, valued for lab precision. Trends focus on AI-driven analysis.
 Rapid Testing Devices: Projected growth of 3.9%-7.7%, linked to on-site needs. Advances emphasize saliva-based kits.
 Consumables: Anticipated growth of 3.5%-7.3%, supporting testing volume. Trends highlight cost-effective reagents.
 Services & Others: Expected growth of 3.4%-7.2%, covering lab outsourcing. Trends focus on digital reporting.

Key Market Players
 Abbott: Offers rapid testing devices for workplaces.
 Thermo Fisher Scientific: Provides advanced screening instruments.
 OraSure Technologies: Specializes in saliva-based tests.
 Drägerwerk: Focuses on breathalyzers for alcohol detection.
 Quest Diagnostics: Emphasizes lab-based screening services.

Porter’s Five Forces Analysis
 Threat of New Entrants: Moderate, due to regulatory barriers, but low-cost rapid tests lower entry hurdles.
 Threat of Substitutes: Low, as alternative methods lack screening accuracy, though self-reporting persists.
 Bargaining Power of Buyers: Moderate, with employers seeking affordable tests, but regulatory standards limit options.
 Bargaining Power of Suppliers: Low, with multiple reagent and device providers.
 Competitive Rivalry: High, with players competing on test sensitivity and speed.

Market Opportunities and Challenges
Opportunities:
 Addressing drug abuse, affecting 296 million people globally.
 Tackling alcohol-related deaths, causing 3 million annually.
 Managing prescription drug abuse, linked to 500,000 deaths yearly.
 Leveraging non-invasive testing for wider adoption.
 Aligning with WHO’s safety initiatives for workplace screening.
 Supporting regulatory mandates in transportation and sports.
Challenges:
 High costs of advanced instruments.
 Regulatory delays, with FDA approvals taking 1-2 years.
 Privacy concerns in workplace testing.
 False positives affecting test reliability.
 Limited awareness in developing regions.
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Drug Screening Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Drug Screening Market in North America (2020-2030)
8.1 Drug Screening Market Size
8.2 Drug Screening Market by End Use
8.3 Competition by Players/Suppliers
8.4 Drug Screening Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Drug Screening Market in South America (2020-2030)
9.1 Drug Screening Market Size
9.2 Drug Screening Market by End Use
9.3 Competition by Players/Suppliers
9.4 Drug Screening Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Drug Screening Market in Asia & Pacific (2020-2030)
10.1 Drug Screening Market Size
10.2 Drug Screening Market by End Use
10.3 Competition by Players/Suppliers
10.4 Drug Screening Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Drug Screening Market in Europe (2020-2030)
11.1 Drug Screening Market Size
11.2 Drug Screening Market by End Use
11.3 Competition by Players/Suppliers
11.4 Drug Screening Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Drug Screening Market in MEA (2020-2030)
12.1 Drug Screening Market Size
12.2 Drug Screening Market by End Use
12.3 Competition by Players/Suppliers
12.4 Drug Screening Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Drug Screening Market (2020-2025)
13.1 Drug Screening Market Size
13.2 Drug Screening Market by End Use
13.3 Competition by Players/Suppliers
13.4 Drug Screening Market Size by Type
Chapter 14 Global Drug Screening Market Forecast (2025-2030)
14.1 Drug Screening Market Size Forecast
14.2 Drug Screening Application Forecast
14.3 Competition by Players/Suppliers
14.4 Drug Screening Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Abbott
15.1.1 Company Profile
15.1.2 Main Business and Drug Screening Information
15.1.3 SWOT Analysis of Abbott
15.1.4 Abbott Drug Screening Sales, Revenue, Price and Gross Margin (2020-2025)
15.2 Thermo Fisher Scientific
15.2.1 Company Profile
15.2.2 Main Business and Drug Screening Information
15.2.3 SWOT Analysis of Thermo Fisher Scientific
15.2.4 Thermo Fisher Scientific Drug Screening Sales, Revenue, Price and Gross Margin (2020-2025)
15.3 OraSure Technologies
15.3.1 Company Profile
15.3.2 Main Business and Drug Screening Information
15.3.3 SWOT Analysis of OraSure Technologies
15.3.4 OraSure Technologies Drug Screening Sales, Revenue, Price and Gross Margin (2020-2025)
15.4 Drägerwerk AG & Co. KGaA
15.4.1 Company Profile
15.4.2 Main Business and Drug Screening Information
15.4.3 SWOT Analysis of Drägerwerk AG & Co. KGaA
15.4.4 Drägerwerk AG & Co. KGaA Drug Screening Sales, Revenue, Price and Gross Margin (2020-2025)
15.5 Quest Diagnostics Incorporated
15.5.1 Company Profile
15.5.2 Main Business and Drug Screening Information
15.5.3 SWOT Analysis of Quest Diagnostics Incorporated
15.5.4 Quest Diagnostics Incorporated Drug Screening Sales, Revenue, Price and Gross Margin (2020-2025)
15.6 Labcorp
15.6.1 Company Profile
15.6.2 Main Business and Drug Screening Information
15.6.3 SWOT Analysis of Labcorp
15.6.4 Labcorp Drug Screening Sales, Revenue, Price and Gross Margin (2020-2025)
15.7 Roche
15.7.1 Company Profile
15.7.2 Main Business and Drug Screening Information
15.7.3 SWOT Analysis of Roche
15.7.4 Roche Drug Screening Sales, Revenue, Price and Gross Margin (2020-2025)
15.8 Siemens Healthcare
15.8.1 Company Profile
15.8.2 Main Business and Drug Screening Information
15.8.3 SWOT Analysis of Siemens Healthcare
15.8.4 Siemens Healthcare Drug Screening Sales, Revenue, Price and Gross Margin (2020-2025)
15.9 Alfa Scientific Designs
15.9.1 Company Profile
15.9.2 Main Business and Drug Screening Information
15.9.3 SWOT Analysis of Alfa Scientific Designs
15.9.4 Alfa Scientific Designs Drug Screening Sales, Revenue, Price and Gross Margin (2020-2025)
15.10 Omega Laboratories
15.10.1 Company Profile
15.10.2 Main Business and Drug Screening Information
15.10.3 SWOT Analysis of Omega Laboratories
15.10.4 Omega Laboratories Drug Screening Sales, Revenue, Price and Gross Margin (2020-2025)
Please ask for sample pages for full companies list
Table Abbreviation And Acronyms
Table Research Scope Of Drug Screening Report
Table Data Sources Of Drug Screening Report
Table Major Assumptions Of Drug Screening Report
Table Drug Screening Classification
Table Drug Screening Applications
Table Drivers Of Drug Screening Market
Table Restraints Of Drug Screening Market
Table Opportunities Of Drug Screening Market
Table Threats Of Drug Screening Market
Table Raw Materials Suppliers
Table Different Production Methods Of Drug Screening
Table Cost Structure Analysis Of Drug Screening
Table Key End Users
Table Latest News Of Drug Screening Market
Table Merger And Acquisition
Table Planned/Future Project Of Drug Screening Market
Table Policy Of Drug Screening Market
Table 2020-2030 North America Drug Screening Market Size
Table 2020-2030 North America Drug Screening Market Size By Application
Table 2020-2025 North America Drug Screening Key Players Revenue
Table 2020-2025 North America Drug Screening Key Players Market Share
Table 2020-2030 North America Drug Screening Market Size By Type
Table 2020-2030 United States Drug Screening Market Size
Table 2020-2030 Canada Drug Screening Market Size
Table 2020-2030 Mexico Drug Screening Market Size
Table 2020-2030 South America Drug Screening Market Size
Table 2020-2030 South America Drug Screening Market Size By Application
Table 2020-2025 South America Drug Screening Key Players Revenue
Table 2020-2025 South America Drug Screening Key Players Market Share
Table 2020-2030 South America Drug Screening Market Size By Type
Table 2020-2030 Brazil Drug Screening Market Size
Table 2020-2030 Argentina Drug Screening Market Size
Table 2020-2030 Chile Drug Screening Market Size
Table 2020-2030 Peru Drug Screening Market Size
Table 2020-2030 Asia & Pacific Drug Screening Market Size
Table 2020-2030 Asia & Pacific Drug Screening Market Size By Application
Table 2020-2025 Asia & Pacific Drug Screening Key Players Revenue
Table 2020-2025 Asia & Pacific Drug Screening Key Players Market Share
Table 2020-2030 Asia & Pacific Drug Screening Market Size By Type
Table 2020-2030 China Drug Screening Market Size
Table 2020-2030 India Drug Screening Market Size
Table 2020-2030 Japan Drug Screening Market Size
Table 2020-2030 South Korea Drug Screening Market Size
Table 2020-2030 Southeast Asia Drug Screening Market Size
Table 2020-2030 Australia Drug Screening Market Size
Table 2020-2030 Europe Drug Screening Market Size
Table 2020-2030 Europe Drug Screening Market Size By Application
Table 2020-2025 Europe Drug Screening Key Players Revenue
Table 2020-2025 Europe Drug Screening Key Players Market Share
Table 2020-2030 Europe Drug Screening Market Size By Type
Table 2020-2030 Germany Drug Screening Market Size
Table 2020-2030 France Drug Screening Market Size
Table 2020-2030 United Kingdom Drug Screening Market Size
Table 2020-2030 Italy Drug Screening Market Size
Table 2020-2030 Spain Drug Screening Market Size
Table 2020-2030 Belgium Drug Screening Market Size
Table 2020-2030 Netherlands Drug Screening Market Size
Table 2020-2030 Austria Drug Screening Market Size
Table 2020-2030 Poland Drug Screening Market Size
Table 2020-2030 Russia Drug Screening Market Size
Table 2020-2030 Mea Drug Screening Market Size
Table 2020-2030 Mea Drug Screening Market Size By Application
Table 2020-2025 Mea Drug Screening Key Players Revenue
Table 2020-2025 Mea Drug Screening Key Players Market Share
Table 2020-2030 Mea Drug Screening Market Size By Type
Table 2020-2030 Egypt Drug Screening Market Size
Table 2020-2030 Israel Drug Screening Market Size
Table 2020-2030 South Africa Drug Screening Market Size
Table 2020-2030 Gulf Cooperation Council Countries Drug Screening Market Size
Table 2020-2030 Turkey Drug Screening Market Size
Table 2020-2025 Global Drug Screening Market Size By Region
Table 2020-2025 Global Drug Screening Market Size Share By Region
Table 2020-2025 Global Drug Screening Market Size By Application
Table 2020-2025 Global Drug Screening Market Share By Application
Table 2020-2025 Global Drug Screening Key Vendors Revenue
Table 2020-2025 Global Drug Screening Key Vendors Market Share
Table 2020-2025 Global Drug Screening Market Size By Type
Table 2020-2025 Global Drug Screening Market Share By Type
Table 2025-2030 Global Drug Screening Market Size By Region
Table 2025-2030 Global Drug Screening Market Size Share By Region
Table 2025-2030 Global Drug Screening Market Size By Application
Table 2025-2030 Global Drug Screening Market Share By Application
Table 2025-2030 Global Drug Screening Key Vendors Revenue
Table 2025-2030 Global Drug Screening Key Vendors Market Share
Table 2025-2030 Global Drug Screening Market Size By Type
Table 2025-2030 Drug Screening Global Market Share By Type

Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Drug Screening Picture
Figure 2020-2030 North America Drug Screening Market Size And Cagr
Figure 2020-2030 South America Drug Screening Market Size And Cagr
Figure 2020-2030 Asia & Pacific Drug Screening Market Size And Cagr
Figure 2020-2030 Europe Drug Screening Market Size And Cagr
Figure 2020-2030 Mea Drug Screening Market Size And Cagr
Figure 2020-2025 Global Drug Screening Market Size And Growth Rate
Figure 2025-2030 Global Drug Screening Market Size And Growth Rate

Research Methodology

  • Market Estimated Methodology:

    Bottom-up & top-down approach, supply & demand approach are the most important method which is used by HDIN Research to estimate the market size.

1)Top-down & Bottom-up Approach

Top-down approach uses a general market size figure and determines the percentage that the objective market represents.

Bottom-up approach size the objective market by collecting the sub-segment information.

2)Supply & Demand Approach

Supply approach is based on assessments of the size of each competitor supplying the objective market.

Demand approach combine end-user data within a market to estimate the objective market size. It is sometimes referred to as bottom-up approach.

  • Forecasting Methodology
  • Numerous factors impacting the market trend are considered for forecast model:
  • New technology and application in the future;
  • New project planned/under contraction;
  • Global and regional underlying economic growth;
  • Threatens of substitute products;
  • Industry expert opinion;
  • Policy and Society implication.
  • Analysis Tools

1)PEST Analysis

PEST Analysis is a simple and widely used tool that helps our client analyze the Political, Economic, Socio-Cultural, and Technological changes in their business environment.

  • Benefits of a PEST analysis:
  • It helps you to spot business opportunities, and it gives you advanced warning of significant threats.
  • It reveals the direction of change within your business environment. This helps you shape what you’re doing, so that you work with change, rather than against it.
  • It helps you avoid starting projects that are likely to fail, for reasons beyond your control.
  • It can help you break free of unconscious assumptions when you enter a new country, region, or market; because it helps you develop an objective view of this new environment.

2)Porter’s Five Force Model Analysis

The Porter’s Five Force Model is a tool that can be used to analyze the opportunities and overall competitive advantage. The five forces that can assist in determining the competitive intensity and potential attractiveness within a specific area.

  • Threat of New Entrants: Profitable industries that yield high returns will attract new firms.
  • Threat of Substitutes: A substitute product uses a different technology to try to solve the same economic need.
  • Bargaining Power of Customers: the ability of customers to put the firm under pressure, which also affects the customer's sensitivity to price changes.
  • Bargaining Power of Suppliers: Suppliers of raw materials, components, labor, and services (such as expertise) to the firm can be a source of power over the firm when there are few substitutes.
  • Competitive Rivalry: For most industries the intensity of competitive rivalry is the major determinant of the competitiveness of the industry.

3)Value Chain Analysis

Value chain analysis is a tool to identify activities, within and around the firm and relating these activities to an assessment of competitive strength. Value chain can be analyzed by primary activities and supportive activities. Primary activities include: inbound logistics, operations, outbound logistics, marketing & sales, service. Support activities include: technology development, human resource management, management, finance, legal, planning.

4)SWOT Analysis

SWOT analysis is a tool used to evaluate a company's competitive position by identifying its strengths, weaknesses, opportunities and threats. The strengths and weakness is the inner factor; the opportunities and threats are the external factor. By analyzing the inner and external factors, the analysis can provide the detail information of the position of a player and the characteristics of the industry.

  • Strengths describe what the player excels at and separates it from the competition
  • Weaknesses stop the player from performing at its optimum level.
  • Opportunities refer to favorable external factors that the player can use to give it a competitive advantage.
  • Threats refer to factors that have the potential to harm the player.
  • Data Sources
Primary Sources Secondary Sources
Face to face/Phone Interviews with market participants, such as:
Manufactures;
Distributors;
End-users;
Experts.
Online Survey
Government/International Organization Data:
Annual Report/Presentation/Fact Book
Internet Source Information
Industry Association Data
Free/Purchased Database
Market Research Report
Book/Journal/News

Why HDIN Research.com?

More options to meet your budget: you can choose Multi-user report, customized report even only specific data you need

 

Plenty of third-party databases and owned databases support

 

Accurate market information supported by Top Fortune 500 Organizations

 

24/7 purchase support and after-service support

 

Protect customer privacy

ABOUT HDIN RESEARCH

HDIN Research focuses on providing market consulting services. As an independent third-party consulting firm, it is committed to providing in-depth market research and analysis reports.

OUR LOCATION

Room 208-069, Floor 2, Building 6, No. 1, Shangdi 10th Street, Haidian District, Beijing, PR China
+86-010-82142830
sales@hdinresearch.com

QUICK LINKS